Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Supiot

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Clinical Nuclear Medicine|April 19, 2016
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: ReplyAurore Goineau, Stéphane Supiot
Translational Cancer Research|February 4, 2022
Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?Stéphane Supiot, Caroline Rousseau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 8, 2025
RecoRad™ 4th edition: The Société française de radiothérapie oncologique's "Recommendations" Commission-driven RecoRad™ 2025 updated versionIgor Latorzeff, Stéphane Supiot
Bulletin Du Cancer|December 28, 2020
[Stereotactic radiotherapy in urologic cancers: Reports from the 3rd international meeting of the Groupe Francophone de Radiothérapie Urologique (GFRU)]Tanguy Perennec, Stéphane Supiot
Prostate Cancer and Prostatic Diseases|August 26, 2022
Should LHRH therapy be continued in patients receiving abiraterone acetate?Loic Ah-Thiane, Stéphane Supiot
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 24, 2008
Using simulated interviews to teach junior medical students to disclose the diagnosis of cancerStéphane Supiot, Angélique Bonnaud-Antignac
European Urology|October 24, 2025
Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019Nicolas Demogeot, Stéphane Supiot, Paul Sargos
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
In Reply to Tsai et alAxel Cailleteau, Tanguy Perennec, Stéphane Supiot
International Journal of Radiation Oncology, Biology, Physics|July 17, 2025
In Reply to Onal et alMartin Langé, Jarad Martin, Stéphane Supiot
Bulletin Du Cancer|December 11, 2020
[Innovation in radiotherapy in 2021]Ingrid Masson, Marie Dutreix, Stéphane Supiot
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Clinical Nuclear Medicine|April 19, 2016
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18FDG PET/CT in a Patient With Prostate Cancer: ReplyAurore Goineau, Stéphane Supiot
Translational Cancer Research|February 4, 2022
Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg?Stéphane Supiot, Caroline Rousseau
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 8, 2025
RecoRad™ 4th edition: The Société française de radiothérapie oncologique's "Recommendations" Commission-driven RecoRad™ 2025 updated versionIgor Latorzeff, Stéphane Supiot
Bulletin Du Cancer|December 28, 2020
[Stereotactic radiotherapy in urologic cancers: Reports from the 3rd international meeting of the Groupe Francophone de Radiothérapie Urologique (GFRU)]Tanguy Perennec, Stéphane Supiot
Prostate Cancer and Prostatic Diseases|August 26, 2022
Should LHRH therapy be continued in patients receiving abiraterone acetate?Loic Ah-Thiane, Stéphane Supiot
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 24, 2008
Using simulated interviews to teach junior medical students to disclose the diagnosis of cancerStéphane Supiot, Angélique Bonnaud-Antignac
European Urology|October 24, 2025
Reply to Mattia Longoni, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019Nicolas Demogeot, Stéphane Supiot, Paul Sargos
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
In Reply to Tsai et alAxel Cailleteau, Tanguy Perennec, Stéphane Supiot
International Journal of Radiation Oncology, Biology, Physics|July 17, 2025
In Reply to Onal et alMartin Langé, Jarad Martin, Stéphane Supiot
Bulletin Du Cancer|December 11, 2020
[Innovation in radiotherapy in 2021]Ingrid Masson, Marie Dutreix, Stéphane Supiot
Pageof 18